Client of a consultant lobbyist
Centre for Commercialization of Regenerative Medicine
- Meetings this Parliament
- 0
- With MPs
- 0
- Since Nov 2021
- 3
- Active registrations
- 0
Most recent reported meeting: Mar 20, 2025.
Lobbying by Centre for Commercialization of Regenerative Medicine: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
Centre for Commercialization of Regenerative Medicine has no active registration. Organizations must register once paid lobbying passes the legal threshold, and their registration ends when it stops.
Reported meetings
Spreadsheet-
Reported by Ingrid Ravary-Konopka · Consultant
- Sean Matthew O'Neill · Director of Parliamentary Affairs, Innovation, Science and Economic Development Canada (ISED)
Supporting the client in efforts to obtain funding through the the Strategic Investment Fund (SIF) program.
-
Reported by Ingrid Ravary-Konopka · Consultant
- Nicholas Kang · Senior Policy Advisor, Prime Minister's Office (PMO)
Supporting the client in efforts to obtain funding through the the Strategic Investment Fund (SIF) program.
-
Reported by Ingrid Ravary-Konopka · Consultant
- Eshan Naik · Director of Policy, Health Canada (HC)
Supporting client through border related queries relating to import/export requirements of biotechnology. Read more
Supporting the client in efforts to obtain funding through the the Strategic Investment Fund (SIF) program.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.